Encompass Health CORP Form 4 insider transactions

Patricia Anne Maryland, a director of Encompass Health Corp, reported acquiring 1,424 shares of common stock on May 1, 2025, as part of an annual grant of restricted stock units.

Director Kevin J. O'Connor reports acquiring 1,424 shares of Encompass Health Corp common stock on May 1, 2025, through an annual grant of restricted stock units.

Christopher R. Reidy, a director of Encompass Health Corp, reports acquiring 1,424 shares of restricted stock units on May 1, 2025, according to a Form 4 filing with the SEC.

Director Nancy M. Schlichting reports acquisition of 1,424 shares of Encompass Health Corp common stock on May 1, 2025, through an annual grant of restricted stock units.

Terrance Williams, a director at Encompass Health Corp, reports acquiring 1,424 shares of common stock through a restricted stock unit grant.

Patrick William Tuer, EVP and Chief Operating Officer of Encompass Health Corp, reports the acquisition of 5,984 shares and disposal of shares on April 30, 2025.

Encompass Health's EVP, General Counsel, and Secretary, John Patrick Darby, exercised stock options and sold shares on April 29, 2025.

Encompass Health's EVP & Chief Financial Officer, Douglas Coltharp, reports exercising stock options and selling shares on April 29, 2025.

Director Edward M. Christie III acquired 268 shares of Encompass Health Corp through the company's deferred stock investment plan at a weighted average price of $102.56 on April 24, 2025.

Director Christopher R. Reidy acquired 360 shares of Encompass Health Corp through the company's deferred stock investment plan at a weighted average price of $98.23 on April 22, 2025.

Patricia Anne Maryland, a director of Encompass Health Corp, received 23 additional restricted stock units (RSUs) due to a dividend payment on April 15, 2025.

Kevin J. O'Connor, a director at Encompass Health Corp, reported the acquisition of 13 restricted stock units (RSUs) resulting from a common stock dividend payment.

Director Joan E. Herman increased her holdings in Encompass Health through the acquisition of 76 shares via a dividend reinvestment program.

Christopher R. Reidy, a director at Encompass Health Corp, acquired 15 restricted stock units (RSUs) due to a dividend payment on April 15, 2025.

Director Edward M. Christie III acquires additional restricted stock units in Encompass Health Corp due to a dividend payment.

Director Leslye G. Katz received 76 additional restricted stock units (RSUs) from Encompass Health due to a dividend payment on common stock.

Greg D. Carmichael, a director at Encompass Health Corp, acquired additional shares through a dividend reinvestment program.

Nancy M. Schlichting, a director at Encompass Health Corp, acquired 33 restricted stock units (RSUs) due to a dividend payment on April 15, 2025.

Terrance Williams, a director at Encompass Health Corp, acquired 23 shares of common stock through a dividend reinvestment program on April 15, 2025.

Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, reports acquisition of non-qualified stock options.

John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reports acquisition of stock options.

Encompass Health Corp's CEO, Mark J. Tarr, acquired 33,086 non-qualified stock options on March 4, 2025, exercisable in installments starting March 4, 2026.

Encompass Health's CEO, Mark Tarr, reports a transaction involving the withholding of shares to cover tax obligations related to restricted stock vesting.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, sold 364 shares of common stock on February 28, 2025, to cover tax obligations related to vesting restricted stock.

Douglas Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, reports changes in beneficial ownership of company stock due to tax withholding obligations and spousal holdings.

EVP, Gen Counsel & Secretary of Encompass Health Corp, John Patrick Darby, sold 416 shares of common stock to cover tax obligations arising from vesting restricted stock.

Edmund Fay, Sr. Vice President and Treasurer of Encompass Health Corp, reports disposition of 276 shares to cover tax obligations.

Andrew L. Price, Chief Accounting Officer of Encompass Health Corp, reports the disposal of 304 shares to cover tax obligations related to vesting restricted stock on February 28, 2025.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, reports disposing of shares to cover tax withholding obligations.

John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reported disposing of shares to cover tax withholding obligations related to restricted stock vesting.